Wealthcare Advisory Partners LLC Aurinia Pharmaceuticals Inc. Transaction History

Wealthcare Advisory Partners LLC

  • $3.43 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$10.0 - $14.52 $5,000 - $7,260
-500 Closed
0 $0
Q1 2021

Apr 30, 2021
BUY
$12.3 - $18.73 $6,150 - $9,365
500 New
500 $6,000
Q2 2020

Jul 29, 2020
SELL
$14.12 - $18.33 $7,060 - $9,165
-500 Closed
0 $0
Q3 2019

Oct 17, 2019
BUY
$5.34 - $6.59 $2,670 - $3,295
500 New
500 $3,000

Others Institutions Holding AUPH

# of Institutions
193
Shares Held
57M
Call Options Held
499K
Put Options Held
637K
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.2B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email